Time-dependent cytokines changes in ultra-rush wasp venom immunotherapy

Area of Science:

• Immunology
• Allergy Research
• Therapeutic Strategies

Background:

• Venom immunotherapy (VIT) aims to modify immune responses to venom allergens.
• Previous research indicated a Th2 to Th1 shift with IL-2 and IFN-γ production during VIT.
• Understanding long-term immune changes post-VIT is crucial.

Purpose of the Study:

• To investigate serum cytokine profiles following VIT for wasp venom hypersensitivity.
• To explore potential new immune pathways involved in VIT-induced desensitization.
• To assess changes in 30 cytokines over 24 weeks of VIT.

Main Methods:

• Serum cytokine levels were measured in 61 patients (43 VIT, 18 control) at multiple time points.
• Patients had hypersensitivity to wasp venom.
• Analysis focused on 30 different cytokines, including IL-2, IFN-γ, IL-12, IL-9, and TGF-β.

Main Results:

• No significant changes in IL-2 and IFN-γ levels were observed post-VIT.
• A significant increase in IL-12 concentration was noted, supporting Th1 pathway involvement.
• Elevated levels of IL-9 and TGF-β suggest a role in regulatory T cell generation.

Conclusions:

• VIT for venom allergies may involve IL-12-mediated Th1 pathway activation.
• Increased IL-9 and TGF-β indicate potential involvement of regulatory T cells in VIT.
• Further research is needed to fully elucidate the mechanisms of VIT.